Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

 Bad research; Not even measuring 100% recovery; the only goal in stroke.

Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

ClinicalTrials.gov IDNCT06402968

SponsorZeenat Qureshi Stroke Institute

Information Provided by

Study Start (Actual)2024-06-01

Primary Completion (Estimated) 2028-01-30

Study Completion (Estimated)2028-07-30

Enrollment (Estimated)1000

Study TypeObservational

Last Update Posted2026-04-07

Study Overview

Brief Summary

The aim is to compare the rate of hypertensive subjects with ICH who reach SBP target with stability within 60 minutes of enrollment, among patients treated with IV clevidipine with those treated with alternate IV antihypertensive regimen.

To learn more, visitClinicalTrials.gov

Contacts and Locations (See Link) 

Participation Criteria (See Link)